Plasma fibrinogen in non insulin dependent diabetes mellitus patients of Tucuman

被引:0
作者
Abregu, AV
Díaz, EI
Velarde, MS
Carrizo, TD
Prado, MM
Aguilar, RP
Fonio, MC
Luciardi, HL
Klyver, ME
机构
[1] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Bioquim Aplicada, Catedra Practica Hosp, RA-4000 San Miguel De Tucuman, Tucuman, Argentina
[2] Hosp Ctr Salud Zenon Santillan San Miguel de Tucu, Serv Endocrinol, RA-4000 San Miguel De Tucuman, Tucuman, Argentina
来源
ACTA BIOQUIMICA CLINICA LATINOAMERICANA | 2000年 / 34卷 / 02期
关键词
fibrinogen; diabetes; cardiovascular disease;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Early development of coronary disease in Non Insulin Dependent Diabetes Mellitus (NIDDM), plasma fibrinogen bevels and its relations with other risk markers were determinated in diabetic patients of San Miguel de Tucuman. 97 NIDDM patients of both ser, and aged from 37 to 65 years, were studied and matched with a control group of 50 healthy subjects, in which plasma Fg, glycemia, fructosamine and lipid profile were determinated. Plasma Fg levels in diabetic patients were 320 +/- 87 mg/dl and 328 +/- 73 mg/dl in women. There were significant difference with control group (men: 257 +/- 48, p< 0,005; women: 256 +/- 38, p< 0.005). Lipid profile of diabetic men showed that total cholesterol and LDL-cholesterol values were statistically lower than diabetic women (p< 0,005 and p< 0,05 respectively), in which an significant and inverse relation between Fg and triglicerides runs observed. FR was higher in hypertensive patients than those normal arterial tension (men: 324 +/- 49 vs 317 +/- 57 mg/dl; women: 328 +/- 46 vs 309 +/- 54 mg/dl). Significant variations were not observed between Fg and age, neither evolution time of disease, smoker and nor smoker, alcohol drinker and not drinker diabetic men. We concluded that increased Fg levels in NIDDM confirm that it is an independent risk marker of cardiovascular disease associated to diabetes.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 34 条
  • [1] AROCHAPINANGO CL, 1995, REV IBEROAMER THROMB, V8, P183
  • [2] BarOn H, 1996, ISRAEL J MED SCI, V32, P397
  • [3] FIBRINOGEN PLASMA-LEVELS AS A MARKER OF THROMBIN ACTIVATION IN DIABETES
    CERIELLO, A
    TABOGA, C
    GIACOMELLO, R
    FALLETI, E
    DESTASIO, G
    MOTZ, E
    LIZZIO, S
    GONANO, F
    BARTOLI, E
    [J]. DIABETES, 1994, 43 (03) : 430 - 432
  • [4] Colorio Cecilia C., 1997, Sangre (Saragossa), V42, P47
  • [5] CREMER P, 1992, DIAGNOSE LABOR, V42, P28
  • [6] Dotevall Annika, 1994, Annals of Epidemiology, V4, P369
  • [7] ERNST E, 1993, BRIT HEART J, V70, P116
  • [8] FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE
    ERNST, E
    RESCH, KL
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) : 956 - 963
  • [9] EPIDEMIOLOGY OF FIBRINOGEN
    FOLSOM, AR
    [J]. EUROPEAN HEART JOURNAL, 1995, 16 : 21 - 24
  • [10] POPULATION CORRELATES OF PLASMA-FIBRINOGEN AND FACTOR-VII, PUTATIVE CARDIOVASCULAR RISK-FACTORS
    FOLSOM, AR
    WU, KK
    DAVIS, CE
    CONLAN, MG
    SORLIE, PD
    SZKLO, M
    [J]. ATHEROSCLEROSIS, 1991, 91 (03) : 191 - 205